Catalyst Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,356,499

Value ($000)

31,661

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	31,661	0.0%	1,356,499	12/31/2025
2025 Q3	11/10/2025	26,240	0.0%	1,331,990	9/30/2025
2025 Q2	8/12/2025	31,164	0.0%	1,436,112	6/30/2025
2025 Q1	9/15/2025	32,174	0.0%	1,326,771	3/31/2025
2024 Q4	2/6/2025	26,023	0.0%	1,246,925	12/31/2024
2024 Q3	11/12/2024	23,215	0.0%	1,167,743	9/30/2024
2024 Q2	8/12/2024	17,301	0.0%	1,116,939	6/30/2024
2024 Q1	5/9/2024	17,144	0.0%	1,075,559	3/31/2024
2023 Q4	2/6/2024	16,076	0.0%	956,333	12/31/2023
2023 Q3	11/8/2023	10,770	0.0%	921,327	9/30/2023
2023 Q2	8/10/2023	11,603	0.0%	863,309	6/30/2023
2023 Q1	5/12/2023	20,214	0.0%	1,219,175	3/31/2023
2022 Q4	2/13/2023	23,202	0.0%	1,247,414	12/31/2022
2022 Q3	11/14/2022	15,600	0.0%	1,215,911	9/30/2022
2022 Q2	8/15/2022	8,282	0.0%	1,181,407	6/30/2022
2022 Q1	5/13/2022	6,893	0.0%	831,365	3/31/2022
2021 Q4	2/11/2022	5,551	0.0%	819,796	12/31/2021
2021 Q3	11/16/2021	4,247	0.0%	801,244	9/30/2021
2021 Q2	8/16/2021	4,596	0.0%	799,239	6/30/2021
2021 Q1	5/17/2021	4,471	0.0%	969,707	3/31/2021
2020 Q4	2/16/2021	3,323	0.0%	994,740	12/31/2020
2020 Q3	11/13/2020	2,674	0.0%	900,298	9/30/2020
2020 Q2	8/20/2020	4,184	0.0%	905,593	6/30/2020
2020 Q1	5/15/2020	3,330	0.0%	864,859	3/31/2020
2019 Q4	2/7/2020	3,037	0.0%	809,820	12/31/2019